Global Point of Care
Switching to a new point-of-care analyzer can be a challenge for clinical end users. When Piedmont Health System changed vendors for its
point-of-care (POC) platform, they found the new provider did not perform as expected. Within months, they returned to Abbott’s
i-STAT System.
This large health system has 22 hospitals and 1,400 locations, including its flagship 622-bed Piedmont Atlanta Hospital. Its providers see 3.4 million patients annually, with a correspondingly high volume of patient testing.
In 2022, Abbott asked customers, including Piedmont, to transition to a new point-of-care (POC) testing system and discontinue use of the i-STAT CHEM8+ and CG4+ cartridges based on discussions with the FDA. Abbott was not sure it could supply Piedmont with enough alternate i-STAT cartridges to meet its high testing volume.
Abbott quickly resolved the issue and, in 2023, Piedmont’s dissatisfaction with its current POCT provider became untenable. Piedmont’s long history with Abbott and the clinical team’s confidence in the i-STAT System’s proven quality eventually convinced lab leadership to reintroduce i-STAT across several locations, including the Piedmont Atlanta Hospital. The go-live process went smoothly with i-STAT and Abbott’s in-person training, reaching over 400 users through more than 56 training sessions.
“As soon as I heard that the i-STAT cartridge issue was resolved, I went back to the lab directors and said, ‘we need to find a pathway back… At the end of the day, it’s clear to everyone who uses the device that i-STAT is superior to the alternative.”1
– Lauranne Scates, BS, RRT, PDE-C, Director of Respiratory Care Services and Sleep Services, Piedmont Atlanta
“Everyone is happy. It’s kind of back to normal for us… so much easier.”2
– Laurie Noltimier, Point of Care Coordinator at Piedmont Newnan Hospital
According to Laurie Noltimier, Point of Care Coordinator at Piedmont Newnan Hospital, working with the new system during the COVID-19 pandemic was a disaster on top of disaster.2
“It’s more than the device–it’s the people in the company. Abbott is a company that is listening to its customers and is making positive changes to its products over time. That’s part of the reason why, even after decades, i-STAT is still state of the art.”1
– Lauranne Scates, BS, RRT, PDE-C, Director of Respiratory Care Services and Sleep Services, Piedmont Atlanta Hospital
*The results/situations shown here are specific to this health care system and may differ from those achieved by other institutions.
A Leader In Rapid Point-of-care Diagnostics.
©2025 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.